SE9704644D0 - New use - Google Patents

New use

Info

Publication number
SE9704644D0
SE9704644D0 SE9704644A SE9704644A SE9704644D0 SE 9704644 D0 SE9704644 D0 SE 9704644D0 SE 9704644 A SE9704644 A SE 9704644A SE 9704644 A SE9704644 A SE 9704644A SE 9704644 D0 SE9704644 D0 SE 9704644D0
Authority
SE
Sweden
Prior art keywords
new use
formoterol
solvate
salt
medicament
Prior art date
Application number
SE9704644A
Other languages
Swedish (sv)
Inventor
Carl Goeran Persson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704644A priority Critical patent/SE9704644D0/en
Publication of SE9704644D0 publication Critical patent/SE9704644D0/en
Priority to PCT/SE1998/002278 priority patent/WO1999030703A1/en
Priority to JP2000538686A priority patent/JP2002508319A/en
Priority to AU18971/99A priority patent/AU1897199A/en
Priority to EP98963701A priority patent/EP1037620A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides the use of an active ingredient which is formoterol, a pharmaceutically acceptable salt or solvate of formoterol, or a solvate of such a salt in the manufacture of a medicament for use in the treatment of an inflammatory and/or allergic condition in the upper airways of a human being.
SE9704644A 1997-12-12 1997-12-12 New use SE9704644D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9704644A SE9704644D0 (en) 1997-12-12 1997-12-12 New use
PCT/SE1998/002278 WO1999030703A1 (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways
JP2000538686A JP2002508319A (en) 1997-12-12 1998-12-10 Use of formoterol in drugs for inflammation / allergy in the upper respiratory tract
AU18971/99A AU1897199A (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways
EP98963701A EP1037620A1 (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704644A SE9704644D0 (en) 1997-12-12 1997-12-12 New use

Publications (1)

Publication Number Publication Date
SE9704644D0 true SE9704644D0 (en) 1997-12-12

Family

ID=20409370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704644A SE9704644D0 (en) 1997-12-12 1997-12-12 New use

Country Status (5)

Country Link
EP (1) EP1037620A1 (en)
JP (1) JP2002508319A (en)
AU (1) AU1897199A (en)
SE (1) SE9704644D0 (en)
WO (1) WO1999030703A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903995D0 (en) * 1999-11-03 1999-11-03 Astra Ab New combination
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
BR0307235A (en) * 2002-02-01 2004-12-07 Atrazeneca Ab Inhalation composition
TW200510277A (en) 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2265276B1 (en) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.
ES2306595B1 (en) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. NAPADISYLATE SALT OF 5- (2 - ((6- (2,2-DIFLUORO-2-PHENYLETOXI) HEXIL) AMINO) -1-HYDROXYETHYL) -8-HYDROXYCHINOLIN-2 (1H) -ONE AS ADRENERGIC RECEIVER AGONIST BETA2 .
ES2320961B1 (en) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) PHENOL AS BETA2 ADRENERGIC RECEIVER AGONISTS.
EP2096105A1 (en) 2008-02-28 2009-09-02 Laboratorios Almirall, S.A. Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
ITRM20110083U1 (en) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire PLATE FOR THE CONSTRUCTION OF TRUCKS FOR AIRPLANES
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
CN105142673B8 (en) 2012-12-18 2018-02-16 阿尔米雷尔有限公司 Novel cyclohexyl and quininuclidinyl carbamate derivatives with beta 2-adrenergic activator and M3 muscarinic antagonists activity
TWI643853B (en) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES
TW201517906A (en) 2013-07-25 2015-05-16 Almirall Sa Combinations comprising MABA compounds and corticosteroids
TWI641373B (en) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES
TW201617343A (en) 2014-09-26 2016-05-16 阿爾米雷爾有限公司 New bicyclic derivatives having [beta]2 adrenergic agonist and M3 muscarinic antagonist activities

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE236617T1 (en) * 1994-12-22 2003-04-15 Astrazeneca Ab AEROSOL MEDICINAL FORMULATIONS
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor

Also Published As

Publication number Publication date
AU1897199A (en) 1999-07-05
JP2002508319A (en) 2002-03-19
WO1999030703A1 (en) 1999-06-24
EP1037620A1 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
SE9704644D0 (en) New use
ATE339954T1 (en) COMBINATIONS OF FORMOTEROL AND TIOTROPIUM SALT
DE60003160D1 (en) COMBINATIONS OF FORMOTEROL AND MOMETASONFUROAT
HUP0203590A2 (en) Remedies for diseases in association with decrease in bone mass
BRPI0412526A (en) compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
AR023972A1 (en) COMPOSITIONS OF MEDICINES BASED ON ANTI-POLINERGICALLY ACTIVE AND BETA-MIMETIC COMPOUNDS
SE9603669D0 (en) New combination
SE9802073D0 (en) New use
WO2002100390A3 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
DE69930259D1 (en) COMPOSITIONS FOR THE USE OF INFLAMMATORY INHIBITORS, ESPECIALLY ANTISEPTIC AND / OR WOUND HEALING AGENTS IN THE UPPER RESPONSE AND / OR EAR
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
SE0002754D0 (en) New pharmaceutical combination formulation and method of treatment with the combination
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
DK0998287T3 (en) Use of levobupivacaine
HUP0000873A2 (en) The use of levobupivacaine in facial surgery
DK1343472T3 (en) Thixotropic nasal spray
DE60043886D1 (en) FORMULATIONS WITH POVIDONE IOD FOR THE TREATMENT OF WOUNDS
SE9902597D0 (en) New use
ATE297732T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE
BR9812531A (en) Combination of components, pharmaceutical preparation, production thereof, and use of the combination or pharmaceutical preparation
HK1073779A1 (en) The use of darifenacin and the salt thereof
ATE185274T1 (en) THERAPEUTIC AGENT AGAINST RISK OF ABORTION
NO995692D0 (en) Novel BPC peptide salts with organ protective activity, the method of their preparation and their use
HUP0203321A2 (en) 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation